BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 21339834)

  • 1. The relationship of prions and translation.
    Wickner RB; Edskes HK; Shewmaker FP; Kryndushkin D; Nemecek J; McGlinchey R; Bateman D
    Wiley Interdiscip Rev RNA; 2010; 1(1):81-9. PubMed ID: 21339834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal levels of ribosome-associated chaperones cure two groups of [PSI+] prion variants.
    Son M; Wickner RB
    Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26298-26306. PubMed ID: 33020283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of charged residues in the N-domain of Sup35 protein on prion [PSI+] stability and propagation.
    Bondarev SA; Shchepachev VV; Kajava AV; Zhouravleva GA
    J Biol Chem; 2013 Oct; 288(40):28503-13. PubMed ID: 23965990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth phase-dependent changes in the size and infectivity of SDS-resistant Sup35p assemblies associated with the [PSI
    Wang K; Melki R; Kabani M
    Mol Microbiol; 2019 Sep; 112(3):932-943. PubMed ID: 31206803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsense-mediated mRNA decay factors cure most [PSI+] prion variants.
    Son M; Wickner RB
    Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1184-E1193. PubMed ID: 29358398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between defects of karyogamy and translation termination in yeast Saccharomyces cerevisiae].
    Borchsenius AS; Repnevskaia MV; Kurischko C; Inge-Vechtomov SG
    Genetika; 2005 Feb; 41(2):178-86. PubMed ID: 15810607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The three faces of Sup35.
    Lyke DR; Dorweiler JE; Manogaran AL
    Yeast; 2019 Aug; 36(8):465-472. PubMed ID: 30963611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutation within the C-terminal domain of Sup35p that affects [PSI+] prion propagation.
    Kabani M; Cosnier B; Bousset L; Rousset JP; Melki R; Fabret C
    Mol Microbiol; 2011 Aug; 81(3):640-58. PubMed ID: 21631606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rnq1 protein protects [PSI^(+)] prion from effect of the PNM mutation].
    Bondarev SA; Likholetova DV; Belousov MV; Zhouravleva GA
    Mol Biol (Mosk); 2017; 51(2):367-371. PubMed ID: 28537243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human J-protein DnaJB6b Cures a Subset of Saccharomyces cerevisiae Prions and Selectively Blocks Assembly of Structurally Related Amyloids.
    Reidy M; Sharma R; Roberts BL; Masison DC
    J Biol Chem; 2016 Feb; 291(8):4035-47. PubMed ID: 26702057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis for transmission barrier and interference between closely related prion proteins in yeast.
    Afanasieva EG; Kushnirov VV; Tuite MF; Ter-Avanesyan MD
    J Biol Chem; 2011 May; 286(18):15773-80. PubMed ID: 21454674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prions are affected by evolution at two levels.
    Wickner RB; Kelly AC
    Cell Mol Life Sci; 2016 Mar; 73(6):1131-44. PubMed ID: 26713322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of a yeast prion protein to an infectious form in bacteria.
    Garrity SJ; Sivanathan V; Dong J; Lindquist S; Hochschild A
    Proc Natl Acad Sci U S A; 2010 Jun; 107(23):10596-601. PubMed ID: 20484678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Horizontal Transmission of Cytosolic Sup35 Prions by Extracellular Vesicles.
    Liu S; Hossinger A; Hofmann JP; Denner P; Vorberg IM
    mBio; 2016 Jul; 7(4):. PubMed ID: 27406566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid diseases of yeast: prions are proteins acting as genes.
    Wickner RB; Edskes HK; Bateman DA; Kelly AC; Gorkovskiy A; Dayani Y; Zhou A
    Essays Biochem; 2014; 56():193-205. PubMed ID: 25131596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the proteasome in the turnover of Sup35p and in [PSI(+) ] prion propagation.
    Kabani M; Redeker V; Melki R
    Mol Microbiol; 2014 May; 92(3):507-28. PubMed ID: 24589377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein 104 (Hsp104)-mediated curing of [
    Zhao X; Rodriguez R; Silberman RE; Ahearn JM; Saidha S; Cummins KC; Eisenberg E; Greene LE
    J Biol Chem; 2017 May; 292(21):8630-8641. PubMed ID: 28373280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose availability dictates the export of the soluble and prion forms of Sup35p via periplasmic or extracellular vesicles.
    Kabani M; Pilard M; Melki R
    Mol Microbiol; 2020 Aug; 114(2):322-332. PubMed ID: 32339313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of GFP-labeling to study prions in yeast.
    Greene LE; Park YN; Masison DC; Eisenberg E
    Protein Pept Lett; 2009; 16(6):635-41. PubMed ID: 19519522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast J-protein Sis1 prevents prion toxicity by moderating depletion of prion protein.
    Kumar J; Reidy M; Masison DC
    Genetics; 2021 Oct; 219(2):. PubMed ID: 34849884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.